-
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
(PAR-19-242)
National Cancer Institute
Application Receipt Date(s): June 18, 2019; June 17, 2020; June 17, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
International Bioethics Research Training Program (D43 Clinical Trial Optional)
(PAR-19-243)
John E. Fogarty International Center
National Human Genome Research Institute
Application Receipt Date(s): June 4, 2019; August 4, 2020, June 4, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
(PAR-19-244)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
National Human Genome Research Institute
Application Receipt Date(s): June 4, 2019, August 4, 2020, June 4, 2021.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)
(PAR-19-246)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): June 12, 2019; September 13, 2019, September 15, 2020
by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the standard application due dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)
(PAR-19-247)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 18, 2019, June 18, 2020, June 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)
(PAR-19-248)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 10, 2019, June 10, 2020, and June 10,2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed)
(PAR-19-249)
National Institute on Aging
National Institute of Environmental Health Sciences
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): July 8, 2019; November 4, 2019; March 9, 2020; July 7 6 , 2020; November 9, 2020; and March 8, 2021, by5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional)
(PAR-19-250)
National Institute of Environmental Health Sciences
National Institute on Aging
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): July 8, 2019, November 4, 2019, March 9, 2020, July 7, 2020, November 9, 2020, March 8, 2021, apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)
(PAR-19-251)
National Cancer Institute
National Institute of Environmental Health Sciences
Application Receipt Date(s): July 2, 2019; November 6, 2019; July 2, 2020; November 6, 2020; July 8, 2021; November 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)
(PAR-19-252)
National Cancer Institute
National Institute of Environmental Health Sciences
Application Receipt Date(s): July 2, 2019; November 6, 2019; July 2, 2020; November 6, 2020; July 8, 2021; November 8, 2021
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Focused Technology Research and Development (R01 - Clinical Trial Not Allowed)
(PAR-19-253)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed)
(PAR-19-254)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed)
(RFA-AI-19-030)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 22, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
(RFA-CA-19-047)
National Cancer Institute
Application Receipt Date(s): August 9, 2019, by 5:00 PM local time of applicant organization.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)
(RFA-DE-20-001)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 29, 2019 by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial Not Allowed
(RFA-FD-19-013)
Food and Drug Administration
Application Receipt Date(s): June 11, 2019 by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)
(RFA-HL-20-005)
National Heart, Lung, and Blood Institute
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 8, 2019 by 5:00 PM local time of applicant organization.
-
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-20-120)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): September 6, 2019 and June 11, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
(RFA-MH-20-135)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): September 27, 2019 and September 30, 2020, and May 27, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Building Interdisciplinary Research Careers in Women's Health (BIRCWH); K12 Clinical Trial Optional
(RFA-OD-19-020)
Office of Research on Women's Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.